Clincosm LogoSign in Get a demo

Oligodendroglioma

Showing NaN - NaN of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life

Withdrawn
  • Anaplastic Oligodendroglioma
  • +2 more
  • Wear novoTTF-200A
  • Quality-of-Life Assessment
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Dec 8, 2020

Giant Cell Glioblastoma, Gliosarcoma, Oligodendroglioma Trial in Los Angeles (autologous dendritic cells pulsed with tumor

Withdrawn
  • Giant Cell Glioblastoma
  • +4 more
  • autologous dendritic cells pulsed with tumor lysate antigen Vaccine
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020

Oligodendroglioma, Astrocytoma, Malignant Glioma Trial in United States (PF-06840003)

Terminated
Has Results
  • Oligodendroglioma
  • +2 more
  • Los Angeles, California
  • +13 more
Jan 13, 2020

Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II Trial in United States (imetelstat sodium)

Terminated
Has Results
  • Anaplastic Astrocytoma
  • +8 more
  • imetelstat sodium
  • Los Angeles, California
  • +10 more
Jun 20, 2018

Glioma, Astrocytoma, Oligodendroglioma Trial in United States (Temozolomide and O6-Benzylguanine)

Terminated
  • Glioma
  • +3 more
  • Temozolomide and O6-Benzylguanine
  • Los Angeles, California
  • +11 more
Feb 7, 2012

Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (TM-601)

Unknown status
  • Malignant Glioma
  • +4 more
  • Birmingham, Alabama
  • +6 more
Jul 16, 2009